Hopital Tenon; Oncologie Radiotherapie

Paris 75970

0 studies enrolling now · 2 studies all time

What they study most

Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN), Non-Small Cell Lung Cancer

Studies at this site

• A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck — Stopped early
• A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111) — Stopped early